Citi keeps a Neutral rating on Fortrea (FTRE) with a $6 price target after adding a “downside 90-day short-term view” on the shares. Citi is cautious on Fortrea, citing the softer demand environment amid biotech delays in funding.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FTRE:
